Altarea SCA (ALTA)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 74.80 |
|---|---|
| 52-week range | 72.00 – 123.96 |
| Return, 1 month / 3 months | −12.3% / −23.4% |
| Return, 1 year / 3 years | −23.9% / +31.9% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 25.2% |
| Worst drawdown (1 year) | -40.5% |
| Average daily value traded | 0.93M EUR |
| Dividend yield | 7.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Altarea is a French real estate company that develops, owns and manages property, with a focus on shopping centres and residential housing. It works as a developer and investor, creating retail destinations and homes, and it also provides asset management services for its properties. Its customers include retailers who lease space in its centres and households who purchase its homes. The company is based in France and concentrates its activity on the French property market.
The shares are listed on the Euronext Paris in France under the code ALTA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Altarea SCA (ALTA) trades on the Euronext Paris in France. It last closed at EUR 74.80 on 19 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 367 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.9% and over the last three months it fell 23.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.4% | ||
| From 52-week high | -38.3% | ||
| Momentum | 25 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -23.4% | ||
| 6-month return | -30.4% | ||
| 12-month return, skipping the last month | -13.2% | ||
| Risk (lower is better) | 60 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 25.2% | ||
| Worst drawdown (1 year) | -40.5% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 0.93M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | −12.3% |
| 3 months | −23.4% |
| 6 months | −30.4% |
| 1 year | −23.9% |
| 3 years | +31.9% |
| 5 years | −45.0% |
Signals
| 50-day / 200-day average | 86.76 / 100.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.96 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jun 2026 | EUR 5.5384 |
| 11 Jun 2025 | EUR 6.0000 |
| 11 Jun 2024 | EUR 6.0000 |
| 30 Jun 2023 | EUR 5.0000 |
| 12 Jun 2023 | EUR 5.0000 |
| 27 May 2022 | EUR 1.9800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.